Enzymatic Reinforcer Treatment

Todd Montgomery [aka Quiktek] (tmont@cerc.wvu.edu)
----------------------------------------------------------------------------
This chemical treatment injects a complex, non-harmful enzyme into the body.
The enzyme is totally self-replicating and attaches to the human-cyberware
interface units. The benefits of this are two-fold:

1) The enzyme produces a membrane over the cyber unit - nerve interface, in
effect reducing the items impact on the body. Thus reducing essence loss if
the enzyme is used before cyberware implantation. This effect has been
termed the "HALO" Effect after the Treatments creator, Dr. John Halos
Carpenter Marcus.

2) The enzyme acts as a sort of caretaker for the delicate interface. This
reduces maintenance cost of cyber items and reduces the need for regular
check-ups. The only disadvantage the treatment has is the fact that the
enzyme lowers the bodies immune system to lower levels. This in effect means
that the user has 1 point less body when dealing with diseases and toxins.
The lowering of the maintenance cost works with diagnostic systems as well.

Cost: 95,000Y
Body Cost: 0.2
Availability: 12/60dys.
Legality: Legal
Street Index: 1.1
Effects: Maintenance cost is cut down to a fourth.

All cyberware implanted after the treatment (except Alpha and Beta Grade,
which uses a similar treatment) has a reduction in Essence Cost of 10%
(Essence Cost = Essence Cost x 0.9).